… in patients with chronic liver disease remains incomplete. A … Currently, the management
of fatigue in chronic liver disease … of fatigue in chronic liver disease. However, evidence and …

… of fatty liver disease, highlighting putative macrophage-mediated mechanisms that link NAFLD
and cardiovascular disease, … of macrophages as therapeutic targets in fatty liver disease. …

… patients with this disease. Alcohol-associated liver disease (ALD) is a major cause of chronic
liver injury, … This ranges from the accumulation of lipids in the liver (steatosis), steatosis with …

… liver disease and non- alcoholic fatty liver disease. We describe the mechanisms
whereby OPN participates in inflammation and liver … liver disease. (Hepatology 2021;73:1594-1608). …

… both contribute to chronic liver disease by abnormal regulation of the gut-liver axis. Thereby,
… of liver tissue. The review further underlines that endotoxemia is observed in both NAFLD …

… liver ECM and diseased liver ECM from different aetiologies. However, currently available
proteomics data on human liver … in different liver diseases and during disease progression and …

… Additionally, resveratrol alleviated nonalcoholic fatty liver disease primarily via AMPK/… fatty
liver disease, but demonstrated the liver-protective effects on nonalcoholic fatty liver disease. …

… liver disease (CLD) and mortality from end-stage liver failure … patients with non-alcoholic fatty
liver disease (NAFLD), with an … NAFLD associated with inflammation, fibrosis and increased …

… mice progresses from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic … in NAFLD
to NASH progression, and liver inflammation is the main mechanism that drives the disease …

… levels of tumor necrosis factor α (TNF-α), alanine aminotransferase (ALT), and serum
aspartate aminotransferase (AST). (18) In addition, the prevalence of SIBO and TNF-α was higher …